Global pharma market growth for 2009 lowered to 2.5%-3.5% by IMS Health

26 April 2009

The value of the global pharmaceutical market is expected to grow by 2.5%-3.5% on a constant-dollar basis in 2009, two percentage points  lower than last indicated (Marketletter November 10, 2008), as the  deteriorating global economic environment continues to affect market  demand, according to the latest report by IMS Health.

The updated forecast predicts global pharmaceutical sales exceeding  $750.0 billion for the year, down from the $820.0+ billion previously  projected, reflecting both the lower growth rate and currency exchange  fluctuations. The sector will feel the impact of the economic climate -  but to a lesser extent than many other industries - through 2010, when a  rebound is expected. The conclusions are drawn from the latest release  of IMS Market Prognosis, a series of strategic market forecasting  publications that incorporate updated macroeconomic indicators  provided by the Economist Intelligence Unit.

Pharma not "recession-proof"

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight